The market for medical cannabis is one of the most dynamically growing market segments in the German healthcare market. The leading players in this market need pharmaceutical expertise and existing customer relationships with doctors, clinics, pharmacies and health insurances.

canna.sales is the leading platform and an innovative service provider for market Access, sales & marketing of medical cannabis products and managed care services in the German healthcare market.

canna.sales is part of SynBiotic SE, the largest listed group in Europe in the hemp and cannabis sector and pursues an EU-focused buy & build investment strategy. The group of companies covers the entire supply chain from cultivation to production to retail – from field to shelf. One of the company’s core businesses is the research & development, production and marketing of cannabinoid- and terpene-based solutions to major societal problems such as pain, sleep and anxiety. In doing so, SynBiotic SE is active not only in the dietary supplement and cosmetics markets, but also in the medical and, in the future, recreational cannabis sector.